Intravenous immunoglobulin treatment of spleen cells from patients with immune thrombocytopenia significantly increases the percentage of myeloid-derived suppressor cells.
Keenan Research Centre for Biomedical Science of St. Michaels Hospital, Rochester, NY, USA.
Rukhsana
R
Aslam
Departments of Medicine and Pathology, University of Rochester School of Medicine, Rochester, NY, USA.
W Richard
WR
Burack
Departments of Medicine and Pathology, University of Rochester School of Medicine, Rochester, NY, USA.
George B
GB
Segel
Keenan Research Centre for Biomedical Science of St. Michaels Hospital, Rochester, NY, USA.|Canadian Blood Services, Toronto, ON, Canada.|Departments of Physiology and Anesthesia, University of Toronto, Toronto, ON, Canada.|Department of Anesthesia and Pain Medicine, Hospital for Sick Children, Toronto, ON, Canada.
Mark
M
McVey
Departments of Medicine and Pathology, University of Rochester School of Medicine, Rochester, NY, USA.
Stephen A
SA
Spence
Keenan Research Centre for Biomedical Science of St. Michaels Hospital, Rochester, NY, USA.|Canadian Blood Services, Toronto, ON, Canada.|Department of Pharmacology, University of Toronto, Toronto, ON, Canada.|Department of Medicine, University of Toronto, Toronto, ON, Canada.|Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.|Division of Haematology and Transfusion Medicine, Lund University, Lund, Sweden.
John W
JW
Semple
D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000494:pharmacology*; D008297:Male; D000072737:Myeloid-Derived Suppressor Cells / Q000276:immunology* / Q000473:pathology; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy* / Q000276:immunology* / Q000473:pathology; D013154:Spleen / Q000276:immunology* / Q000473:pathology
D016756:Immunoglobulins, Intravenous
immune thrombocytopenia; intravenous immunoglobulin; myeloid derived suppressor cells